Conference Details


Organizing Committee


Bayhelix China Pharmaceutical Awards

2016 BayHelix China Pharmaceutical Awards

For several years, BayHelix has hosted the China Pharmaceutical Awards, celebrating outstanding individuals and companies for their achievement and contribution to the local healthcare ecosystem. This year, BayHelix and BioCentury jointly hosted The "Bridge to Innovation" China Healthcare Summit (October 18-19, Shanghai), and expanded and presented the awards as the "China Healthcare Awards" in five categories:

R&D Achievement of the Year

Recognizing a scientific discovery in China with direct impact on drug and/or medtech R&D or a significant achievement in pharmaceutical development milestones.


Hua Medicine Ltd.

Successful completion of the Phase II clinical trial of the first innovative diabetes first-in-class asset in China.

Deal of the Year

Recognizing a groundbreaking pharmaceutical and/or medtech fund-raising, collaboration, technology transfer, licensing, M&A or joint venture that involves a Chinese entity, either within China or cross-border.


Innovent Biologics Inc./Eli Lilly and Co.

The largest licensing and collaboration deal between a domestic Chinese company and a multinational company, creating a fully integrated partnership ranging from drug discovery, clinical development, manufacturing, regulatory to commercialization.

Commercial Achievement of the Year

Recognizing a creative model that delivered superior value to patients/payers in China and commercial success.


Kingmed Diagnostics

From a small university spin off growing to over 8,000 employees,  KingMed is recognized for its success in pioneering commercial clinical testing in China, serving more than 16,000 hospitals in 28 provinces.

Company of the Year

Recognizing an outstanding company in China that has made a significant impact on the landscape, reputation and ecosystem of China’s pharmaceutical, medtech and/or healthcare industry.


WuXi Apptec

Transformative capability and technology platform company that is enabling more than 2,000 partners to discover and develop better and innovative medicines faster for patients around the world.

Person of the Year

Recognizing an outstanding individual whose contributions have changed the landscape, reputation, and ecosystem for drug and/or medtech R&D, deal transactions, and/or commercialization etc. in China.


Samantha Du, Ph.D., Founder, Chairman & CEO, Zai Lab Ltd.